ProBio and UCI Therapeutics Sign a Strategic Cooperation MOU for Comprehensive Collaboration in Gene Delivery Technologies, Including Viral and Non-Viral Approaches

ProBio Extends Congratulations to InnoBation Bio on MFDS Clearance of IBC101 Program

ProBio Signs Collaboration Agreement with Cell Resources Corporation, a Subsidiary of Alfresa Holdings Corporation for Cell Therapy Development

ProBio announces the appointment of Dr. Li Chen, as the Chief Executive Officer

ProBio Congratulates TG ImmunoPharma on FDA Clearance of Clinical Trial for TGI-5 Monoclonal Antibody

ProBio signs viral vector manufacturing MOU with Curocell for next-generation CAR-T therapy

The MOU between ProBio and NuclixBio

ProBio Partners with Epi Biotech to Advance Hair Loss Antibody Therapy

ProBio Congratulates ABL Bio’s IND Clearance of ABL103 Program from MFDS

Dx&Vx Signs Strategic Partnership with ProBio for Novel Drug Development

ProBio Congratulates IMBiologics on FDA Clearance of IND Application for Innovative Bispecific Antibody Drug Project (IMB-101)

ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

ProBio Congratulates Eutilex’s IND Clearance from MFDS

ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

A Joint Collaboration Between Bio Immunitas and ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform

ProBio Congratulates Selecxine’s IND Clearance from MFDS

Program CD47, provided the CMC service by ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics，partners of ProBio, received IND clearance from NMPA for clinical trial

ProBio Licenses Novel Fc Silencing Technology from mAbsolve

ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) – the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new